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A B S T R A C T
Background
Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until bleeding is controlled. Different
resuscitation strategies have been used to maintain the blood pressure in trauma patients until bleeding is controlled. However, while
maintaining blood pressure may prevent shock, it may worsen bleeding.
Objectives
To assess the effects of early versus delayed, and larger versus smaller volume of fluid administration in trauma patients with bleeding.
Search strategy
We searched the CENTRAL (The Cochrane Library 2008, Issue 4), the Cochrane Injuries Group’s Specialised Register (searched
October 2008), MEDLINE (to October 2008), EMBASE (to October 2008), the National Research Register (in Current controlled
trials.gov; searched October 2008) and the Science Citation Index (to October 2008). We checked reference lists of identified articles
and contacted authors and experts in the field.
Selection criteria
Randomised trials of the timing and volume of intravenous fluid administration in trauma patients with bleeding. Trials in which
different types of intravenous fluid were compared were excluded.
Data collection and analysis
Two authors independently extracted data and assessed trial quality.
Main results
We did not combine the results quantitatively because the interventions and patient populations were so diverse.
Early versus delayed fluid administration
Three trials reported mortality and two coagulation data.
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In the first trial (n=598) relative risk (RR) for death with early fluid administration was 1.26 (95% confidence interval of 1.00−1.58).
The weighted mean differences (WMD) for prothrombin time and partial thromboplastin time were 2.7 (95% CI 0.9−4.5) and 4.3
(95% CI 1.74−6.9) seconds respectively.
In the second trial (n=50) RR for death with early blood transfusionwas 5.4 (95%CI 0.3−107.1). TheWMD for partial thromboplastin
time was 7.0 (95% CI 6.0−8.0) seconds. In the third trial (n=1309) RR for death with early fluid administration was 1.06 (95% CI
0.77−1.47).
Larger versus smaller volume of fluid administration
Three trials reported mortality and one coagulation data.
In the first trial (n=36) RR for death with a larger volume of fluid resuscitation was 0.80 (95% CI 0.28−22.29). Prothrombin time
and partial thromboplastin time were 14.8 and 47.3 seconds in those who received a larger volume of fluid, as compared to 13.9 and
35.1 seconds in the comparison group.
In the second trial (n=110) RR for death with a high systolic blood pressure resuscitation target (100mmHg) maintained with a larger
volume of fluid, as compared to low systolic blood pressure resuscitation target (70mmHg) maintained with a smaller volume of fluid
was 1.00 (95% CI 0.26−3.81). In the third trial (n=25) there were no deaths.
Authors’ conclusions
We found no evidence from randomised controlled trials for or against early or larger volume of intravenous fluid administration in
uncontrolled haemorrhage. There is continuing uncertainty about the best fluid administration strategy in bleeding trauma patients.
Further randomised controlled trials are needed to establish the most effective fluid resuscitation strategy.
P L A I N L A N G U A G E S U M M A R Y
No evidence from trials to support or not to support the use of early or larger volume intravenous fluid in uncontrolled bleeding
About one third of injury deaths are due to shock from blood loss. Preventing shock in people with uncontrolled bleeding is, therefore,
very important and is generally done by giving fluids intravenously. The aim is to maintain blood pressure and reduce tissue damage.
The review of trials found that there is uncertainty about the best time to give fluid and what volume of fluid should be given. While
increasing fluids will maintain blood pressure, it may also worsen bleeding by diluting clotting factors in the blood. More research is
needed.
B A C K G R O U N D
In 1990 approximately five million people died worldwide as a
result of injury (Murray 1996). For people younger than 35 years,
injury is now the leading cause of death. Nevertheless, the global
epidemic of injury is only beginning. It is estimated that by 2020,
deaths from injury will have increased from 5.1 million to 8.4
million (Murray 1997). About one third of injury deaths are due
to haemorrhagic shock (Deakin 1994). Acute blood loss following
injury leads to a reduction in tissue perfusion and tissue oxygen
delivery that, if prolonged, causes lactic acidosis and organ fail-
ure. Treatment of haemorrhagic shock involves maintaining blood
pressure and tissue perfusion until the bleeding is controlled. Over
the past 50 years, a number of resuscitation strategies have been
used tomaintain the blood pressure in trauma patients until bleed-
ing is controlled. The evidence for the effectiveness of these ap-
proaches has been the subject of a number of systematic reviews
by the Cochrane Injuries Group and by others.
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Pre-hospital use of medical anti-shock trousers
Medical anti-shock trousers (MAST) were first used in the Viet-
nam War to stabilise patients with haemorrhagic shock during
transportation. After the war, MAST became widely used in the
care of bleeding trauma patients. MAST increases blood pressure
by compressing the blood vessels in the legs, thus increasing sys-
temic vascular resistance, and by shunting blood from the lower
body to the brain, heart and lungs. It was hoped that by increasing
venous return to the heart, MAST would maintain blood flow to
vital organs until definitive care was given. Nevertheless, a system-
atic review of randomised controlled trials of MAST use in pre-
hospital trauma care provided no evidence that MAST increases
survival, and a suggestion that it may increase the risk of death.
The pooled relative risk of death with MAST was 1.13 (95% CI
0.97−1.32) (Dickinson 1999).
Paramedic ambulance crews
In high-income countries, an increasing number of ambulance
crews include a paramedic trained in advance life support.
Paramedics receive extra training in intubation, intravenous can-
nulation, and the administration of intravenous fluids. Only a
small proportion of paramedic-attended trauma patients require
intubation (1%), but a larger proportion (18%) receive intra-
venous fluids (Nicholl 1998). Because of the strong conviction
amongst the public and medical profession that paramedic inter-
vention is beneficial, it has been difficult to conduct randomised
controlled trials comparing paramedic and non-paramedic trauma
care. However, a review and meta-analysis of four cohort studies
gave a significantly increased (p=0.03) risk of death in paramedic
attended patients (RR=1.26) (Nicholl 1998). Because of the po-
tential for confounding by injury severity, the validity of inferences
from cohort studies must be questioned. Nevertheless, the results
are consistent with the hypothesis that efforts by paramedics to
raise the blood pressure of bleeding trauma patients may be coun-
terproductive.
Colloid fluid resuscitation
Intravenous fluid administration, with colloid or crystalloid solu-
tions, is the mainstay of the non-surgical management of bleeding
trauma patients. Colloids are better than crystalloid solutions in
expanding the circulation, because they are retained within the
blood vessels to a greater extent. Crystalloid solutions rapidly leak
out of the blood vessels into the interstitial spaces. After a colloid
infusion, the increase in the circulating volume is about the same
as the volume of colloid infused, whereas only about one quar-
ter of the volume of a crystalloid infusion remains in the blood
vessels (Weil 1999). Although colloids are effective in expanding
the circulation there is no evidence that this improves outcome in
critically ill patients (Alderson 2000).
The systematic reviews of medical anti-shock trousers, paramedic
resuscitation and colloid administration call into question the ben-
efits of raising the blood pressure in bleeding trauma patients. But
by what mechanisms could fluid resuscitation adversely affect out-
come? Stern, using a swinemodel of near-fatal haemorrhage, found
that attempts to restore blood pressure with crystalloid resulted in
increased haemorrhage volume and markedly higher mortality (
Stern 1993). It was postulated that the increased pulse pressure
from crystalloid resuscitation might cause the mechanical disrup-
tion of blood clots and worsen bleeding. It has also been proposed
that fluid administration might also worsen bleeding by diluting
clotting factors. In view of the concerns raised by the previous
systematic reviews and by the results of animal models of haem-
orrhagic hypovolaemia, we have conducted a systematic review of
the effect on mortality of early versus delayed fluid resuscitation,
and of larger versus smaller fluid volumes.
O B J E C T I V E S
To examine the effect on mortality and coagulation times of two
intravenous fluid administration strategies in the management of
haemorrhagic hypovolaemia: early compared to delayed adminis-
tration and larger compared to smaller volume of fluid adminis-
tered.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All unconfounded randomised and quasi-randomised controlled
trials of the timing or volume of intravenous fluid administration
in haemorrhagic hypovolaemia.
Types of participants
Patients of all ages with haemorrhagic hypovolaemia of traumatic
or non-traumatic origin. Because the physiological response to
bleeding and to fluid resuscitation is likely to be similar among
patients with internal bleeding (e.g. bleeding peptic ulcer) and
those with external bleeding (e.g. penetrating trauma), both types
of participants were included.
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Types of interventions
Intravenous fluids including crystalloid solutions, colloids, plasma
and blood. Trials in which the timing or volume of fluid admin-
istration is confounded by the type of intravenous fluid given −
for example, a trial comparing the administration of 1000ml of
colloid with 500ml blood − were excluded.
Types of outcome measures
Mortality from all causes at the end of the follow-up period sched-
uled for each trial. We sought mortality data in simple categorical
form, and we did not extract data on time to death. If a report did
not include the numbers of deaths in each group, we sought these
data from the authors. We also sought data on prothrombin time
and partial thromboplastin time during fluid administration.
Search methods for identification of studies
Searches were not restricted language, date or publication status.
Electronic searches
We searched:
• CENTRAL ((The Cochrane Library 2008, Issue 4),
• MEDLINE (1966 to October 2008),
• National Research Register (October 2008),
• EMBASE (1980 to October 2008),
• Web of Science; Science Citation Index (to October 2008),
• Cochrane Injuries Group Trials Register (searched October
2008),
• Current Controlled Trials (Searched October 2008).
The search strategy can be found in Appendix 1.
Searching other resources
We checked the reference lists of all included studies and contacted
authors and experts in the field. The Science Citation Index was
checked for eligible papers that cited two of the trials (Bickell
1994, Blair 1986) included in this review.
Data collection and analysis
Selection of studies
One reviewer (IK) examined the electronic search results for re-
ports of possibly relevant trials and these reports were then re-
trieved in full. The first reviewer (IK) also contacted experts in
the field for unpublished and ongoing trials. A second reviewer
(FB) examined 10% of the electronic search results to check for
agreement on eligibility criteria. Two reviewers (FB, IK) applied
the selection criteria independently to the trial reports, resolving
disagreements by discussion with a third (IR).
Data extraction and management
Two reviewers (IK, FB) independently extracted information on
the following: method of allocation concealment, number of ran-
domised patients, type of participants and the interventions, loss
to follow-up and length of follow-up. The outcome data sought
were numbers of deaths, prothrombin time and partial thrombo-
plastin time. The reviewers were not blinded to the authors or
journal when doing this. Results were compared and any differ-
ences resolved by discussion.
Where there was insufficient information in the published report
we attempted to contact the authors for clarification.
Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment
particularly affects the results of studies, two reviewers (IK, FB)
scored this quality on the scale used by Higgins 2008 as shown
below, assigning ’No’ to poorest quality and ’Yes’ to best quality:
• Yes = trials deemed to have taken adequate measures to
conceal allocation (i.e. central randomisation; serially numbered,
opaque, sealed envelopes; or other description that contained
elements convincing of concealment)
• Unclear = trials in which the authors either did not report
an allocation concealment approach at all or reported an
approach that did not fall into one of the other categories
• No = trials in which concealment was inadequate (such as
alternation or reference to case record numbers or to dates of
birth).
Where the method used to conceal allocation was not clearly re-
ported, the author(s) were contacted, if possible, for clarification.
We then compared the scores allocated and resolved differences
by discussion.
Data synthesis
The following comparisons were made:
• early versus delayed intravenous fluids administration
• larger versus smaller volume of intravenous fluids
administration.
The relative risk of death and 95% confidence interval (95% CI)
was calculated, such that a relative risk of more than 1 indicated a
higher risk of death in the first group named. The relative risk was
chosen as it is more readily applied to the clinical situation. The
weighted mean difference was calculated for coagulation times.
Because of differences in the types of patients and in the nature of
the trial interventions we did not pool the data in our analysis.
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R E S U L T S
Description of studies
See: Characteristics of included studies.
Our original search strategy found 4,487 potentially eligible re-
ports of which six unpublished trials met the inclusion criteria. A
further 655 abstracts were retrieved from a search carried out in
August 2007, and another search in October 2008 retrieved 261
abstracts. All search results were scanned by two individuals for
potentially relevant studies. No new trials that met the inclusion
criteria were indentified from these search results.
A. Early versus delayed intravenous fluids
administration
Bickell 1994
This trial compared early versus delayed administration of Ringer’s
acetate solution, an isotonic crystalloid, in patients with penetrat-
ing torso injuries during the prehospital phase. Participants were
adults over 16 years of age, with gunshot or stab wounds to the
torso, and who had a systolic blood pressure of <90mmHg. Partic-
ipants with head injury, a Revised Trauma Score of zero or minor
injuries were excluded. During the trial, 22 patients (8%) in the
delayed resuscitation group were inadvertently given fluid prior to
surgery in violation of the protocol. Follow-up was until hospital
discharge.
Blair 1986
This trial compared early versus delayed blood transfusion in pa-
tients with acute gastrointestinal haemorrhage during the first 24
hours after admission. Patients with oesophageal varices were ex-
cluded because of abnormal coagulation related to liver diseases.
Follow-up was until hospital discharge.
Turner 2000
This trial compared early versus no/delayed fluid administration in
trauma patients. Participants were all trauma patients with mod-
erate to severe injuries, over the age of 16 years of age. Patients
who were pregnant or without vital signs were excluded. Fluids
given were crystalloids. Protocol compliance was poor with 31%
of patients in the early fluid group receiving fluids and 80% of
the delayed/no fluid group not given fluids. Follow-up was for six
months.
B. Larger versus smaller volume of intravenous fluids
administration
Dunham 1991
This trial compared fluid resuscitation using the rapid infusion
system and conventional fluid administration method in trauma
patients during the first 24 hours of admission. Participants were
between 14 and 60 years of age and had a systolic blood pressure
of <90mmHg. Patients with a Glasgow Coma Score of <5, cardiac
arrest, quadriplegia and myocardial infarct on admission were ex-
cluded. Fluids given included red blood cells, platelets, fresh frozen
plasma and crystalloids. Follow-up was until hospital discharge.
Dutton 2002
This trial compared the maintenance of target systolic blood pres-
sures of 70 and 100mmHg respectively with fluid restriction
(Plasma, Plasmalyte-A and red blood cells in the first 24 hours)
in patients with blunt and penetrating trauma injuries. All partic-
ipants suffered haemorrhagic shock with a systolic blood pressure
(SBP) of <90mmHg. Patients with head or spinal cord injury were
excluded. Length of follow-up period was until death or hospital
discharge.
Fortune 1987
This trial compared the maintenance of haematocrit at 30% and
40% respectively with blood transfusion in patients following
acute injuries and haemorrhage during the first 72 hours of ad-
mission. All participants had sustained Class III/IV haemorrhage
with a systolic blood pressure of <90mmHg, heart rate > 100 beats
per minute. Follow-up was for three days.
Risk of bias in included studies
A. Early versus delayed intravenous fluids
administration
Bickell 1994
Randomisationwas by alternate day allocationwhich allowed fore-
knowledge of treatment allocation. Data were analysed as ran-
domised, on an intention-to-treat basis. Blinding of outcome as-
sessment was not stated. There was no loss to follow-up.
Blair 1986
Contact with the author of this trial established the adequacy of
the randomisation method used. Allocation was by opening sealed
envelopes at the time of patient presentation. Blinding of outcome
assessment was not stated. Data were analysed as randomised, on
an intention-to-treat basis. There was no loss to follow-up.
Turner 2000
Paramedics rather than trauma patients were randomised, using
computer-generated random numbers, stratified by base stations.
The paramedics crossed over to alternate fluid protocol halfway
through the trial and they were not blinded. Data were analysed as
randomised, on an intention-to-treat basis. There was no blinding
in outcome assessment.
B. Larger versus smaller volume of intravenous fluids
administration
Dunham 1991
Methodof randomisation and allocation concealmentwas unclear.
Blinding of outcome assessment was not stated. Data on eight
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patients who died during the first 12 hours were excluded from
the analysis except for the outcome of death.
Dutton 2002
Randomisation was by selecting the next numbered envelope from
a supply maintained in the Trauma Resuscitation Unit. The en-
velopes were made up in batches of 20 (10 to each group), thor-
oughly mixed, and then numbered for selection. Allocation was
blinded to all Unit personnel prior to enrolment . Only the pa-
tients were blinded to the allocation in this trial after randomisa-
tion. Data were analysed as randomised, on an intention-to-treat
basis. Blinding of outcome assessment was not stated. There was
no loss to follow-up.
Fortune 1987
Contact with the co-author of this trial established the adequacy of
the randomisation method used. Sequences of random allocations
were generated by a statistician not involved with the study, in sets
of sealed opaque envelopes, differentiated by sex and age groups.
Both patients and physicians had no prior knowledge of which arm
the patient would be assigned to. Blinding of outcome assessment
was not stated. There was no loss to follow-up.
The characteristics of each trial are listed in Characteristics of
included studies.
Effects of interventions
A. Early versus delayed fluid administration
One trial (Bickell 1994) reported mortality and coagulation time
on a total of 598 hypotensive trauma patients with penetrating
torso injuries. Mortality was 116/309 (38%) in the early and
86/289 (30%) in the delayed administration group. The relative
risk for death with early fluid administration was 1.26 (95% CI
1.00−1.58). Prothrombin time and partial thromboplastin time
were 14.1 and 31.8 seconds in the early, as compared to 11.4 and
27.5 seconds in the delayed administration group. The weighted
mean difference (WMD) for prothrombin time and partial throm-
boplastin time was 2.7 (95% CI 0.90−4.5) and 4.3 seconds (95%
CI 1.7−6.9) respectively.
One trial (Blair 1986) reported mortality and coagulation time on
a total of 50 hypotensive patients with acute upper gastrointestinal
haemorrhage. Mortality was 2/24 (8%) in the early as compared
to 0/26 (0%) in the delayed transfused group. The relative risk for
death with early blood transfusion was 5.4 (95% CI 0.3−107.1).
Activated partial thromboplastin time was 48 in the early, as com-
pared to 41 seconds in the delayed administration group. The
WMD for partial thromboplastin time was 7.0 seconds (95% CI
6.0−8.0).
In one trial (Turner 2000) on a total of 1309 trauma patients,
mortality was 73/699 (10.4%) in the early as compared to 60/610
(9.8%) in the delayed/no fluid administration group. The relative
risk for death with early fluid administration was 1.06 (95% CI
0.77−1.47). There were no data on coagulation times.
B. Larger versus smaller volume of fluid
administration
One trial (Dunham 1991) reported mortality and coagulation
time on a total of 36 hypotensive trauma patients. Mortality was
5/20 (25%) in the group who received a larger volume of fluids
administered conventionally, as compared to 5/16 (31%) in the
group who received a smaller volume of fluids administered using
the Rapid Infusion System. The relative risk for death is 0.80 (95%
CI 0.28−2.29). Prothrombin time and partial thromboplastin
time were 14.8 and 47.3 seconds in the group who received a
larger volume of fluid as compared to 13.9 and 35.1 seconds in
the comparison group.
In one trial (Dutton 2002) on a total of 110 hypotensive patients
with blunt and penetrating injuries, mortality was 4/55 (7.3%)
in the group administered a larger volume and 4/55 (7.3%) in
the group administered a smaller volume (1000ml less than in the
intervention group). The relative risk for death is 1.00 (95% CI
0.26−3.81). There were no data on coagulation times.
In one trial (Fortune 1987) on a total of 25 hypotensive patients
with acute injury and haemorrhage, there were no data on mor-
tality in both the groups administered with larger or smaller vol-
ume of blood. Contact with the co-author established that there
were no deaths in either group. There were no data on coagulation
times.
D I S C U S S I O N
This review found insufficient evidence for or against the use of
early or larger volume fluid resuscitation in the treatment of un-
controlled haemorrhage. While vigorous fluid resuscitation may
be life-saving in some patients, results from clinical trials are in-
conclusive.
Every year, tens of thousands of patients receive intravenous fluids
in the management of bleeding. The Advanced Trauma Life Sup-
port (ATLS) protocol of the American College of Surgeons rec-
ommends the liberal use of isotonic crystalloid to correct hypoten-
sion in bleeding trauma patients. Nevertheless, we could find no
reliable evidence to support or not to support this recommenda-
tion. While we cannot exclude the possibility that we overlooked a
large high-quality randomised controlled trial showing that early
or larger volume fluid resuscitation is beneficial, we believe that
this is unlikely. To identify eligible trials we screened over 4,000
potentially relevant reports, we searched the reference lists of in-
cluded trials, and contacted authors and experts in the field.
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Six published trials were reviewed. Due to their heterogeneity, in
terms of types of patients and types of fluids used, we did not
attempt to perform a meta-analysis of the studies.
Death was chosen as the primary end-point in this review for two
reasons. First, death is a clinically relevant outcome that matters
to patients. Second, death is not prone to measurement error and
to reporting bias, as are pathophysiological end points. Mortal-
ity data were available for all six included trials, three on the ef-
fect of early fluid resuscitation (Bickell 1994; Blair 1986; Turner
2000) and three on the effect of larger volume fluid resuscitation
(Dunham 1991, Dutton 2002, Fortune 1987).Three trials exam-
ined the effect of fluid administration on coagulation. Clotting
times were significantly elevated in the immediate resuscitation
groups (Bickell 1994, Blair 1986) and the group who received
a larger volume (Dunham 1991). Method of randomisation was
inadequate in two trials (Bickell 1994, Turner 2000) and unclear
in another (Dunham 1991). Allocation concealment was inade-
quate in two trials (Bickell 1994; Turner 2000). Because inade-
quate randomisation and poorly concealed allocation can bias the
results of randomised controlled trials, and because this bias can
be large and can operate in either direction, the impact of early or
larger volume fluid resuscitation on mortality remains difficult to
estimate.
Interpretation of results also needs to be cautious due to the het-
erogeneous nature of traumatic injuries encountered in these tri-
als. Haemorrhagic shock can be caused by a variety of underly-
ing anatomic injuries. Some of these injuries, such as posterior
pelvic fractures, may be more amenable to hypotensive manage-
ment maintained by smaller volume of fluid, than liver injuries
where haemostasis can be difficult to achieve (Dutton 2002).
The use of medical anti-shock trousers, early and larger volume
fluid administration and colloid resuscitation are based on the idea
that raising the blood pressure in bleeding trauma patients will
maintain tissue perfusion and so prevent haemorrhagic shock and
its consequences. However, while maintaining blood pressure may
prevent shock, it may worsen bleeding. In view of the lack of ev-
idence for or against the effectiveness of currently recommended
resuscitation protocols and the potential for harm, the balance of
risks and benefits of contemporary resuscitation practice warrants
careful consideration. Further randomised controlled trials are re-
quired to identify the most effective strategies for the fluid man-
agement of bleeding trauma patients.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found no evidence for or against the use of early or larger
volume intravenous fluid administration in uncontrolled haemor-
rhage. There is uncertainty about the effectiveness of fluid resus-
citation in patients with bleeding following trauma.
Implications for research
Large, well concealed, randomised controlled trials are urgently
needed to establish the optimal fluid resuscitation strategy in
haemorrhaging trauma patients, with a focus on specific types of
injuries likely to benefit from the appropriate resuscitation strat-
egy in terms of timing and volume of fluids given.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bickell 1994
Methods Quasi-randomised controlled trial.
(Allocation by alternation - odd and even numbered days of the month.)
Participants 598 trauma patients >16 years of age with penetrating injuries and hypotension.
Mean age = 31 years.
Exclusion: pregnancy, Revised Trauma Score = 0, minor injuries not requiring surgery.
Interventions 1) 870ml of Ringer’s solution pre-hospital (n=309).
2) 92ml of Ringer’s solution with IV cannulation pre-hospital (n=289).
Outcomes • Haemodynamic variables,
• amount of fluids given,
• intraoperative blood loss,
• post-op
• complications,
• process of care,
• death.
Notes Patients in both groups were treated with a standard paramedical protocol as appropriate until after IV
cannulation.
22/289(8%) in delayed fluids group were inadvertently given fluids in violation of the protocol. Results
were analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No
Blair 1986
Methods Randomised controlled trial.
(Allocation by opening sealed envelopes.)
Participants 50 patients with acute severe upper gastrointestinal haemorrhage.
Mean age = 62
Exclusion: patients with oesophageal varices due to abnormal coagulation.
Interventions 1) >/= 2 units of blood in first 24 hr (n=24).
2) No blood transfusion during first 24 hr
(n=26).
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Blair 1986 (Continued)
Outcomes • Coagulation times,
• Haematocrit,
• re-bleeding rate,
• volume of blood given,
• death.
Notes 5/26 patients in the no-blood group received blood in the first 24 hours when their Hgb < 8g/dl.
Results were analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes
Dunham 1991
Methods Randomised controlled trial.
(Allocation unclear.)
Participants 36 trauma patients >14 <60 years of age with hypotension.
Mean age = 35.
Exclusion: Glasgow Coma Score <5,
cardiac arrest,
quadriplegia,
myocardial infarct.
Interventions 1. 23,661ml of IV fluids (red blood cells, fresh frozen plasma, platelets and Plasmalyte-A)in first 24 hours via
conventional fluid administration (CFA) (n=20).
2. 20,224 ml of IV fluids (red blood cells, fresh frozen plasma, platelets and Plasmalyte-A, given via the RIS
(Rapid Infusion System). (n=16).
Outcomes • Blood loss,
• temperature,
• Haematocrit,
• coagulation times,
• serum Lactate,
• base excess,
• ionised calcium,
• costs,
• death.
Notes Data from 3/20 patients in CFA group and 5/16 patients in RIS group who died in the first 12 hours were excluded
from subsequent analyses except for death.
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Dutton 2002
Methods Randomised controlled trial.
(Allocation by drawing the next numbered envelope from a batch of 20, thoroughlymixed but sequentially
numbered envelopes.)
Participants 110 trauma patients >16, <55 years of age with blunt and penetrating injuries and in shock.
Mean age = 31
Exclusion: pregnancy, no pulse, head or spinal injury, known end-organ ischaemic disease.
Interventions 1. Bolus of fluids (plasma, Plasmalyte-A and packed red blood cells) to maintain systolic blood
pressure of >100mmHg (n=55).
2. 1000ml less of fluids (plasma, Plasmalyte-A and packed red blood cells) to maintain a lower blood
pressure of 70mmHg (n=55).
Outcomes • Duration of bleeding,
• average ISS,
• death.
Notes All patients maintained at a haematocrit of at least 25%.
Results analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes
Fortune 1987
Methods Randomised controlled trial.
(Random allocations generated by a statistician blinded to the study, in sets of sealed opaque envelopes.)
Participants 25 patients with acute injury and haemorrhage, hypotensive, urine output < 20ml/hr.
Mean age = 46.
Exclusion: history of myocardial infarction in previous year as a higher haematocrit could be harmful.
Interventions 1. >/= 5 units of blood to maintain Haematocrit at 40% (n=13).
2. < 5 units of blood transfusion to maintain Haematocrit at 30% (n=12).
Outcomes • Cardiopulmonary status,
• death not reported, but later obtained from the author.
Notes Study was designed to test the hypothesis that sufficient oxygen can be provided at lower haematocrit of
30%.
Allocation concealment was later reported to be adequate when co-author was contacted.
Risk of bias
Item Authors’ judgement Description
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Fortune 1987 (Continued)
Allocation concealment? Yes
Turner 2000
Methods Randomised controlled trial (of paramedics using computer-generated random numbers, stratified by base
stations).
Participants 1309 trauma patients > 16 years of age.
Exclusion: pregnancy,
no vital signs.
Interventions 1. >/= 1 unit of fluids of Hartmann’s solution and Haemacell pre-hospital (n=699)
2. Delayed/no fluids pre-hospital (n=610).
Outcomes • Post-op complications,
• process of care,
• costs,
• death.
Notes Protocol compliance was poor with 31% of the fluid group receiving fluids and 80% of the no fluid group
not given fluids.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search strategy
Cochrane Inuries Group’s Specialised Register (searched 22 October 2008)
(((fluid* or volume or plasma or blood) and (replace* or therap* or substitut* or restorat* or resuscitat*)) or ((fluid* or volume or plasma
or blood) and (administrat* or challenge or perfusion or intravenous or shock))) and (timing or volume)
CENTRAL (The Cochrane Library issue 4, 2008)
#1 MeSH descriptor Fluid Therapy explode all trees
#2 MeSH descriptor Infusions, Intravenous explode all trees
#3 (fluid* or volume or plasma or blood) near3 (replace* or therap* or substitut* or restorat* or resuscitat*):ti or (fluid* or volume
or plasma or blood) near3 (replace* or therap* or substitut* or restorat* or resuscitat*):ab
#4 (fluid* or volume or plasma or blood) near3 (administrat* or challenge or perfusion or intravenous or shock):ti or (fluid* or
volume or plasma or blood) near3 (challenge or perfusion or intravenous or shock):ab
#5 (#1 OR #2 OR #3 OR #4)
#6 MeSH descriptor Time Factors, this term only
#7 (timing or delayed or intermediate or early or selective or rapid or immediate*):ti
#8 rapid near3 infusion*
#9 (small* or large*) near3 volume
#10 MeSH descriptor Plasma Volume, this term only
#11 (#6 OR #7 OR #8 OR #9 OR #10)
#12 (#5 AND #11)
MEDLINE 1966 to October 2008
1. exp Fluid Therapy/
2. exp Infusions, Intravenous/
3. ((fluid* or volume or plasma or blood) adj3 (replace* or therap* or substitut* or restorat* or resuscitat*)).ab,ti.
4. ((fluid* or volume or plasma or blood) adj3 (administrat* or challenge or perfusion or intravenous or shock)).ti,ab.
5. 1 or 2 or 3 or 4
6. exp Time Factors/
7. exp Plasma Volume/
8. (timing or delayed or intermediate or early or selective or rapid or immediate*).ti.
9. (rapid adj3 infusion*).ab,ti.
10. ((small* or large*) adj3 volume).ab,ti.
11. 6 or 7 or 8 or 9 or 10
12. 5 and 11
13. randomi?ed.ab,ti.
14. randomized controlled trial.pt.
15. controlled clinical trial.pt.
16. placebo.ab.
17. clinical trials as topic.sh.
18. randomly.ab.
19. trial.ti.
20. or/13-19
21. humans.sh.
22. 20 and 21
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23. 22 and 12
EMBASE 1980 to October 2008
1. exp Fluid Therapy/
2. exp Infusions, Intravenous/
3. ((fluid* or volume or plasma or blood) adj3 (replace* or therap* or substitut* or restorat* or resuscitat*)).ab,ti.
4. ((fluid* or volume or plasma or blood) adj3 (administrat* or challenge or perfusion or intravenous or shock)).ti,ab.
5. 1 or 2 or 3 or 4
6. (timing or delayed or intermediate or early or selective or rapid or immediate*).ti.
7. (rapid adj3 infusion*).ab,ti.
8. ((small* or large*) adj3 volume*).ab,ti.
9. *time factors/
10. *plasma volume/
11. 6 or 7 or 8 or 9 or 10
12. 5 and 11
13. exp Randomized Controlled Trial/
14. exp controlled clinical trial/
15. randomi?ed.ab.
16. placebo.ab.
17. exp Clinical Trial/
18. randomly.ab.
19. trial.ti.
20. 13 or 14 or 15 or 16 or 17 or 18 or 19
21. exp human/
22. 20 and 21
23. 22 and 12
PubMed (searched 22 Oct 2008; limit: last 90 days)
#1 Search “Fluid Therapy”[Mesh] OR “Infusions, Intravenous”[Mesh]
#2 Search (fluid* or volume or plasma or blood) AND (replace* or therap* or substitut* or restorat* or resuscitat*) Field: Title/
Abstract
#3 Search (fluid* or volume or plasma or blood) AND (administrat* or challenge or perfusion or intravenous or shock) Field: Title/
Abstract
#4 #1 or #2 or #3
#5 Search (small* or large*) AND volume Field: Title/Abstract
#6 Search rapid infusion* Field: Title/Abstract
#7 Search (timing or delayed or intermediate or early or selective or rapid or immediate*):ti Field: Title
#8 #5 or #6 or #7
#9 #4 and #8
#10 Search (randomised OR randomized OR randomly OR random order OR random sequence OR random allocation OR randomly
allocated OR at random OR randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh])
NOT ((models, animal[mh] OR Animals[mh] OR Animal Experimentation[mh] OR Disease Models, Animal[mh] OR Animals,
Laboratory[mh]) NOT (Humans[mh]))
#11 #9 and #10
Web of Science; Science citation index: searched 22 Oct 2008
#1 Title=((fluid* or volume or plasma or blood) and (replace* or therap* or substitut* or restorat* or resuscitat*)) AND Title=(timing
or volume) AND Topic=(randomised OR randomized OR randomly OR random order OR random sequence OR random allocation
OR randomly allocated OR at random OR randomized controlled trial OR controlled clinical trial OR randomized controlled trials)
#2 Title=((fluid* or volume or plasma or blood) and (administrat* or challenge or perfusion or intravenous or shock)) AND
Title=(timing or volume) AND Topic=(randomised OR randomized OR randomly OR random order OR random sequence OR
random allocation OR randomly allocated OR at random OR randomized controlled trial OR controlled clinical trial OR randomized
controlled trials)
#3 #1 or #2
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WH A T ’ S N E W
Last assessed as up-to-date: 21 October 2008.
6 November 2008 New search has been performed Search updated. No new trials were found for inclusion in the review.
H I S T O R Y
Protocol first published: Issue 3, 2000
Review first published: Issue 1, 2001
20 August 2008 Amended Converted to new review format.
12 April 2003 New search has been performed Data have now become available from a trial (Dutton 2002) which was ongoing
in 2000. These data did not affect the results or the overall conclusion of the
review. Types of injuries may be an important consideration in the research
design of future trials in fluids resuscitation.
C O N T R I B U T I O N S O F A U T H O R S
IK screened citations, extracted data, contacted authors, entered data into RevMan and helped to write the review. IR developed the
protocol, and helped to write the review. FB screened citations, extracted data, and commented on the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Institute of Child Health, University of London, UK.
15Timing and volume of fluid administration for patients with bleeding (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
External sources
• Global Programme on Evidence for Health Policy (GPE), World Health Organisation, Switzerland.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Hemorrhage [∗therapy]; Infusions, Intravenous; Plasma Substitutes [∗administration & dosage]; Randomized Controlled Trials as
Topic; Time Factors; Wounds and Injuries [blood; ∗complications]
MeSH check words
Humans
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